Rivastigmine News
Rivastigmine currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Rivastigmine with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Symptomatic treatment of mild to moderately severe Alzheimer's dementia. Symptomatic treatment of mild to moderately severe dementia in patients with idiopathic Parkinson's disease.
- Evidence level: L5
- Predicted indications (20):
- glaucoma (99.3%)
- acute intermittent porphyria (98.2%)
- psychogenic movement disorders (98.2%)
- primary orthostatic tremor (98.0%)
- tremor-nystagmus-duodenal ulcer syndrome (98.0%)
- benign shuddering attacks (97.9%)
- extrapyramidal and movement disease (97.9%)
- benign paroxysmal tonic upgaze of childhood with ataxia (97.9%)
- chronic tic disorder (97.8%)
- Pick disease (97.6%)
- primary hereditary glaucoma (96.9%)
- lingual-facial-buccal dyskinesia (96.6%)
- open-angle glaucoma (96.1%)
- myoclonic dystonia (95.2%)
- myoclonus-dystonia syndrome (95.1%)
- focal hand dystonia (94.5%)
- torsion dystonia (92.8%)
- early-onset generalized dystonia (92.8%)
- Alzheimer disease (92.2%)
- parkinsonian disorder (92.0%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.